(Report ID: 141086) Drug interactions analysis of:
Aranesp, Eprex, Allopurinol, Verapamil Hydrochloride, Furosemide, Rabeprazole Sodium, Warfarin Sodium, Digoxin, Medroxyprogesterone Acetate, RamiprilMany drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 20, 2008, eHealthMe analyzes 10,180,594 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 20, 2008: 3 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 141086 | Jun, 20, 2006 | Not specified | Female |
List of drugs the patient takes:
| Drug |
Aranesp |
Eprex |
Allopurinol |
Verapamil Hydrochloride |
Furosemide |
Rabeprazole Sodium |
Warfarin Sodium |
Digoxin |
Medroxyprogesterone Acetate |
Ramipril |
| Name |
Anaemia |
Aplasia Pure Red Cell |
Atrial Fibrillation |
Gastric Haemorrhage |
Injection Site Reaction |
Pruritus |
Rash Erythematous |
Rash Pruritic |
Therapeutic Response Decreased |
Results from eHealthMe: 3 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Anaemia | 1 (33.33%) |
Aplasia Pure Red Cell | 3 (100.00%) |
Atrial Fibrillation | 3 (100.00%) |
Gastric Haemorrhage | 3 (100.00%) |
Injection Site Reaction | 2 (66.67%) |
Pruritus | 2 (66.67%) |
Rash Erythematous | 2 (66.67%) |
Rash Pruritic | 1 (33.33%) |
Therapeutic Response Decreased | 3 (100.00%) |
3) Top co-used drugs drugs reported for the past 12 months:
Death: 0
Cancer: 0
| Name | Count (% of total reports) |
1 | Therapeutic Response Decreased | 3 (100.00%) |
2 | Gastric Haemorrhage | 3 (100.00%) |
3 | Atrial Fibrillation | 3 (100.00%) |
4 | Aplasia Pure Red Cell | 3 (100.00%) |
5 | Pruritus | 2 (66.67%) |
6 | Rash Erythematous | 2 (66.67%) |
7 | Injection Site Reaction | 2 (66.67%) |
8 | Serum Ferritin Increased | 1 (33.33%) |
9 | Vitamin B12 Increased | 1 (33.33%) |
10 | Reticulocytopenia | 1 (33.33%) |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
